Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Bone Diseases, Metabolic × Calcium Carbonate × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Osteoporosis 4 Breast Neoplasms 2 Vitamin D Deficiency 1 Prostatic Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Polycystic Ovary Syndrome 1 Lymphoma, Non-Hodgkin 1 Lymphoma 1 Bone Diseases, Metabolic 1 Adenomatous Polyps 1 Adenoma 1

Interventions

Denosumab 3 Zoledronic Acid 2 Vitamin D 2 Risedronic Acid 2 Toremifene 1 Letrozole 1 Ibandronic Acid 1 Geritol 1 Calcium Carbonate 1 Calcium 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00352846 2013-07-02

Effect of Zoledronic Acid on Chemotherapy Induced Bone Loss

M.D. Anderson Cancer Center

Phase 3 Completed

135 enrolled 4 charts

Bone Diseases, Metabolic, Lymphoma, Lymphoma, Non-Hodgkin

Data powered by HemOnc (CC BY 4.0) Colophon ⚡